PROGRESS
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Reduced Ejection Fraction
- Stadium
- klaar
- Middel
- elamipretide
- Populatie
- Hartfalen
- Fase
- II
- First Patient In
- 1 september 2016
- Last Patient In
- 18 augustus 2017
- Last Patient Last Visit
- 30 september 2017
National Lead
prof. dr. A. Voors
Cardioloog
Studiedirecteur
dr. D.J.A. Lok
Cardioloog
Contact Bestuur
